Headline News

 

Wholly-Owned Affiliate In Japan Established by Amgen

Posted on April 02, 2020

FDA Accelerates Development of Novel Therapies for COVID-19

Posted on April 02, 2020

First patient outside U.S. treated in global Kevzara® clinical trial program for patients with severe COVID-19

Posted on March 31, 2020

Landmark Phase 3 VOYAGER PAD Study of XARELTO® Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease

Posted on March 31, 2020

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use and Landmark New Partnership with U.S. Department of Health & Human Services

Posted on March 31, 2020

Bristol Myers Squibb and bluebird bio Announce Submission of Biologics License Application for Anti-BCMA CAR T Cell Therapy to FDA

Posted on March 31, 2020

Brilinta Reduced Bleeding vs Dual Therapy in High-Risk Coronary Patients from Phase IV TWILIGHT Trial

Posted on March 31, 2020

Lupin’s Inhalation Research Center Receives EIR From U.S. FDA

Posted on March 31, 2020

Farxiga Reduced the Incidence of Heart Failure Worsening or Cardiovascular Death in Landmark Phase III DAPA-HF Trial

Posted on March 31, 2020

Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus

Posted on March 31, 2020

Moderna Provides Update on the Impact of COVID-19 on Clinical Program Development and Business Operation

Posted on March 31, 2020

Lupin and Mylan announce Positive European Medicines Agency Approval of Nepexto®, Biosimilar Etanercept

Posted on March 31, 2020

Consignment of 30 Million Hydroxychloroquine Tablets in Novartis Donation

Posted on March 31, 2020

C2 PHARMA Opens Access to Safety Stock of DIGOXIN API for Potential COVID-19 Combination Treatment

Posted on March 30, 2020

Novartis’ Commitment to Support the Global COVID-19 Pandemic Response and Donates 130 Million Doses of Hydroxychloroquine

Posted on March 26, 2020